340 related articles for article (PubMed ID: 2355954)
41. Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: influence on cure rates and risk of second cancer.
Levinsen M; Rotevatn EØ; Rosthøj S; Nersting J; Abrahamsson J; Appell ML; Bergan S; Bechensteen AG; Harila-Saari A; Heyman M; Jonsson OG; Maxild JB; Niemi M; Söderhäll S; Schmiegelow K;
Pediatr Blood Cancer; 2014 May; 61(5):797-802. PubMed ID: 24395436
[TBL] [Abstract][Full Text] [Related]
42. Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood.
Toyoda Y; Manabe A; Tsuchida M; Hanada R; Ikuta K; Okimoto Y; Ohara A; Ohkawa Y; Mori T; Ishimoto K; Sato T; Kaneko T; Maeda M; Koike Ki; Shitara T; Hoshi Y; Hosoya R; Tsunematsu Y; Bessho F; Nakazawa S; Saito T
J Clin Oncol; 2000 Apr; 18(7):1508-16. PubMed ID: 10735899
[TBL] [Abstract][Full Text] [Related]
43. Dose reduction of coadministered 6-mercaptopurine decreases myelotoxicity following high-dose methotrexate in childhood leukemia.
Nygaard U; Schmiegelow K
Leukemia; 2003 Jul; 17(7):1344-8. PubMed ID: 12835723
[TBL] [Abstract][Full Text] [Related]
44. Intermediate-dose methotrexate and intravenous 6-mercaptopurine chemotherapy for children with acute lymphoblastic leukemia who did not respond to initial induction therapy.
Ogden AK; Pollock BH; Bernstein ML; Camitta B; Buchanan GR
J Pediatr Hematol Oncol; 2002; 24(3):182-7. PubMed ID: 11990303
[TBL] [Abstract][Full Text] [Related]
45. Myelotoxicity, pharmacokinetics, and relapse rate with methotrexate/6-mercaptopurine maintenance therapy of childhood acute lymphoblastic leukemia.
Schmiegelow K; Ifversen M
Pediatr Hematol Oncol; 1996; 13(5):433-41. PubMed ID: 10897815
[TBL] [Abstract][Full Text] [Related]
46. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America.
Gupta S; Antillon FA; Bonilla M; Fu L; Howard SC; Ribeiro RC; Sung L
Cancer; 2011 Oct; 117(20):4788-95. PubMed ID: 21446043
[TBL] [Abstract][Full Text] [Related]
47. White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate.
Schmiegelow K; Pulczynska MK; Seip M
Pediatr Hematol Oncol; 1988; 5(4):259-67. PubMed ID: 3152971
[TBL] [Abstract][Full Text] [Related]
48. Changes of cerebral biopterin and biogenic amine metabolism in leukemic children receiving 5 g/m2 intravenous methotrexate.
Millot F; Dhondt JL; Mazingue F; Mechinaud F; Ingrand P; Guilhot F
Pediatr Res; 1995 Feb; 37(2):151-4. PubMed ID: 7537364
[TBL] [Abstract][Full Text] [Related]
49. Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma.
Shimasaki N; Mori T; Torii C; Sato R; Shimada H; Tanigawara Y; Kosaki K; Takahashi T
J Pediatr Hematol Oncol; 2008 May; 30(5):347-52. PubMed ID: 18458567
[TBL] [Abstract][Full Text] [Related]
50. Medication errors on oral chemotherapy in children with acute lymphoblastic leukemia in a developing country.
Oberoi S; Trehan A; Marwaha RK
Pediatr Blood Cancer; 2014 Dec; 61(12):2218-22. PubMed ID: 25175850
[TBL] [Abstract][Full Text] [Related]
51. Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism.
Brackett J; Schafer ES; Leung DH; Bernhardt MB
Pediatr Blood Cancer; 2014 Jun; 61(6):1114-7. PubMed ID: 24376133
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of 6-Thioguanine and 6-Mercaptopurine Combination Maintenance Therapy of Childhood ALL: Hypothesis and Case Report.
Nielsen SN; Frandsen TL; Nersting J; Hjalgrim LL; Schmiegelow K
J Pediatr Hematol Oncol; 2015 Apr; 37(3):e206-9. PubMed ID: 25171455
[TBL] [Abstract][Full Text] [Related]
53. Role of base-excision repair in the treatment of childhood acute lymphoblastic leukaemia with 6-mercaptopurine and high doses of methotrexate.
Stanczyk M; Sliwinski T; Trelinska J; Cuchra M; Markiewicz L; Dziki L; Bieniek A; Bielecka-Kowalska A; Kowalski M; Pastorczak A; Szemraj J; Mlynarski W; Majsterek I
Mutat Res; 2012 Jan; 741(1-2):13-21. PubMed ID: 22064329
[TBL] [Abstract][Full Text] [Related]
54. [Effect of dose intensity and therapy-induced leukocytopenia in intensive therapy on the prognosis of acute lymphatic leukemia in childhood. Results in 213 patients of the COALL-85 study].
Gobrecht O; Göbel U; Graubner U; Gutjahr P; Schöck V; Spaar HJ; Janka-Schaub GE
Klin Padiatr; 1992; 204(4):230-5. PubMed ID: 1518258
[TBL] [Abstract][Full Text] [Related]
55. Patients' Adherence in the Maintenance Therapy of Children and Adolescents with Acute Lymphoblastic Leukemia.
Kremeike K; Juergens C; Alz H; Reinhardt D
Klin Padiatr; 2015 Nov; 227(6-7):329-34. PubMed ID: 26457956
[TBL] [Abstract][Full Text] [Related]
56. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia.
Lilleyman JS; Lennard L
Lancet; 1994 May; 343(8907):1188-90. PubMed ID: 7909868
[TBL] [Abstract][Full Text] [Related]
57. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
[TBL] [Abstract][Full Text] [Related]
58. Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate.
Innocenti F; Danesi R; Di Paolo A; Loru B; Favre C; Nardi M; Bocci G; Nardini D; Macchia P; Del Tacca M
Cancer Chemother Pharmacol; 1996; 37(5):409-14. PubMed ID: 8599862
[TBL] [Abstract][Full Text] [Related]
59. Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia.
Lennard L; Lilleyman JS
J Clin Oncol; 1989 Dec; 7(12):1816-23. PubMed ID: 2585022
[TBL] [Abstract][Full Text] [Related]
60. 6-mercaptopurine plasma levels in children with acute lymphoblastic leukemia: relation to relapse risk and myelotoxicity.
Hayder S; Lafolie P; Björk O; Peterson C
Ther Drug Monit; 1989 Nov; 11(6):617-22. PubMed ID: 2595740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
